Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001021408-03-003090
Filing Date
2003-02-18
Accepted
2003-02-18 16:26:03
Documents
7
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1627165
3 FOURTH AMENDMENT TO THE LOAN AGREEMENT dex10196.htm EX-10.196 15253
4 SUBSIDIARIES dex21.htm EX-21 45154
5 CONSENT OF INDEPENDENT ACCOUNTANTS dex231.htm EX-23.1 1710
6 INDEPENDENT AUDITOR'S CONSENT dex232.htm EX-23.2 1616
7 CERTIFICATION dex991.htm EX-99.1 3578
8 CERTIFICATION dex992.htm EX-99.2 3561
  Complete submission text file 0001021408-03-003090.txt   1700267
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

EIN.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27570 | Film No.: 03571257
SIC: 8731 Services-Commercial Physical & Biological Research